CDNA

CareDx, Inc.

Halal Rating :
Comfortable
Last Price $20.62 Last updated:
Market Cap $1.62b
7D Change -9.8%
1 Year Change 76.39%
Company Overview Use of Interest Company Impact Justification for our Halal Rating Recent News

Company Overview

Industries
  • Services
  • Healthcare
  • Services – Health
Exchange NASDAQ
Next Earnings Date Oct. 31, 2024

CareDx, Inc. is a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value diagnostic solutions for transplant patients. The company offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey, and is a leading provider of genomics-based information for transplant patients.

The company's primary products include AlloSure® and AlloMap®, which are non-invasive blood tests used by transplant physicians to better monitor patients for organ rejection. These tests represent a significant advancement over traditional biopsy-based monitoring methods, offering less invasive and more accurate ways to assess transplant health.

Use of Interest

Reporting Date Total Revenue Total Operating Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
Sept. 30, 2024 $82.88m $93.38m - - 0.00% 0.00%
June 30, 2024 $92.27m $96.37m - - 0.00% 0.00%
March 31, 2024 $72.05m $91.39m - - 0.00% 0.00%

Company Impact

Help us evaluate CareDx, Inc.'s impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.

Contribute

Recent News & Updates